BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 30559738)

  • 1. Hantavirus-Driven PD-L1/PD-L2 Upregulation: An Imperfect Viral Immune Evasion Mechanism.
    Raftery MJ; Abdelaziz MO; Hofmann J; Schönrich G
    Front Immunol; 2018; 9():2560. PubMed ID: 30559738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
    Pittet CL; Newcombe J; Prat A; Arbour N
    J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice.
    Li Y; Kilani RT; Pakyari M; Leung G; Nabai L; Ghahary A
    J Cell Physiol; 2018 Mar; 233(3):2590-2601. PubMed ID: 28777458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications.
    Wolkow N; Jakobiec FA; Afrogheh AH; Eagle RC; Pai SI; Faquin WC
    Am J Ophthalmol; 2019 Apr; 200():226-241. PubMed ID: 30633894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function.
    Jones D; Como CN; Jing L; Blackmon A; Neff CP; Krueger O; Bubak AN; Palmer BE; Koelle DM; Nagel MA
    PLoS Pathog; 2019 Mar; 15(3):e1007650. PubMed ID: 30870532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic Cells (DCs) as "Fire Accelerants" of Hantaviral Pathogenesis.
    Schönrich G; Raftery MJ
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31540199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
    Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
    J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance.
    Schönrich G; Raftery MJ
    Front Cell Infect Microbiol; 2019; 9():207. PubMed ID: 31263684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.
    Jiao Q; Liu C; Li W; Li W; Fang F; Qian Q; Zhang X
    Clin Exp Immunol; 2017 Jun; 188(3):420-429. PubMed ID: 28052400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PI3Kδ Differentially Regulates Poly I:C- and Human Metapneumovirus-Induced PD-L1 and PD-L2 Expression in Human Bronchial Epithelial Cells.
    Ogawa T; Kan-O K; Shiota A; Fujita A; Ishii Y; Fukuyama S; Matsumoto K
    Front Immunol; 2021; 12():767666. PubMed ID: 34899719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2.
    Xu Y; Wu Y; Zhang S; Ma P; Jin X; Wang Z; Yao M; Zhang E; Tao B; Qin Y; Chen H; Liu A; Chen M; Xiao M; Lu C; Mao R; Fan Y
    Cell Rep; 2019 Dec; 29(11):3435-3447.e4. PubMed ID: 31825827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
    Cristino AS; Nourse J; West RA; Sabdia MB; Law SC; Gunawardana J; Vari F; Mujaj S; Thillaiyampalam G; Snell C; Gough M; Keane C; Gandhi MK
    Blood; 2019 Dec; 134(25):2261-2270. PubMed ID: 31856276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PD-1/PD-Ls in the pathogenesis of IgG4-related disease.
    Zhang X; Lu H; Peng L; Zhou J; Wang M; Li J; Liu Z; Zhang W; Zhao Y; Zeng X; Lu L
    Rheumatology (Oxford); 2022 Feb; 61(2):815-825. PubMed ID: 33930105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
    [No Abstract]   [Full Text] [Related]  

  • 16. TLR2 directing PD-L2 expression inhibit T cells response in Schistosoma japonicum infection.
    Gao Y; Chen L; Hou M; Chen Y; Ji M; Wu H; Wu G
    PLoS One; 2013; 8(12):e82480. PubMed ID: 24376539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands.
    Mosconi C; de Arruda JAA; de Farias ACR; Oliveira GAQ; de Paula HM; Fonseca FP; Mesquita RA; Silva TA; Mendonça EF; Batista AC
    Oral Oncol; 2019 Jan; 88():95-101. PubMed ID: 30616805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection.
    Zhang E; Zhang X; Liu J; Wang B; Tian Y; Kosinska AD; Ma Z; Xu Y; Dittmer U; Roggendorf M; Yang D; Lu M
    PLoS One; 2011; 6(10):e26196. PubMed ID: 22022563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals.
    Philips EA; Garcia-España A; Tocheva AS; Ahearn IM; Adam KR; Pan R; Mor A; Kong XP
    J Biol Chem; 2020 Apr; 295(14):4372-4380. PubMed ID: 31882544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1-expressing dendritic cells contribute to viral resistance during acute HSV-1 infection.
    Bryant-Hudson KM; Carr DJ
    Clin Dev Immunol; 2012; 2012():924619. PubMed ID: 22474484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.